Evaluation de l’exposition tabagique chez un groupe de « fumeurs actifs » et un groupe de « fumeurs passifs ».

La fumée de cigarette expose les fumeurs et leur entourage, à des substances chimiques toxiques responsables de maladies graves voire mortelles. L’évaluation de l’exposition au tabac permet d’apprécier le degré de dépendance et l’intensité de l’imprégnation tabagique.Notre étude porte sur l’évaluation de cette exposition chez un groupe de fumeurs chroniques et un groupe de « fumeurs passifs »et ceci par détermination des marqueurs du tabagisme :-Evaluer les taux de nicotine et de cotinine urinaires chez l’ensemble des sujets par chromatographie liquide haute performance (HPLC-DAD) utilisant une méthode d’extraction en phase solide (SPE) ;-Evaluer le taux de la carboxyhémoglobine chez ces sujets ; -Evaluer certains paramètres biochimiques (bilan lipidique et glycémie) et hémobiologiques (numération sanguine) chez ces sujets ; relever les perturbations éventuelles

Assessment of acute and sub-acute toxicity of olive pomace in female Wistar rats

Objective: Olive Pomace (OP) is considered to be a rich source of phenolic compounds. Recently many researches showed a broad biological activity of this by-product of the olive oil production process in addition to their emergence as value-added materials with potential applications in the pharmaceutical, food, and nutraceutical industries. The present study is aimed to evaluate in vivo toxicological activities of OP. Materials and Methods: The qualitative phytochemical analysis aims to determine the key phytoconstituents found in OP. For the in vivo study, two types of tests are performed: acute and 28-day repeated oral toxicity studies in Wistar rats for evaluation of hematological, biochemical, and histological parameters. Results: The qualitative phytochemical analysis has revealed the presence of polyphenols, flavonoids, tannins, saponins, quinones, anthraquinones, terpenoids, and compounds reduced in our methanol extract of OP. In acute oral toxicity, no treatment-related death or toxic signs are observed in female rats for 14 days in 200, 2000, 3000, and 5000 mg/kg doses, besides LD50 value is found to be up to 2000 mg/kg bodyweight. As for the Globally Harmonized System of Classification and Labelling of Chemicals. 28-days sub-acute toxicity study is carried in female rats at four dose levels (3.12, 31.25, 125 and 500 mg/kg), no changes in observation related death and toxic signs when compared with control. The hematological and biochemical investigation shows a significant change (p>0.05) in the high-level doses (500 mg/kg). Conclusions: According to the findings of this study, OP extract has the potential to be used to generate new anti-cancer and antioxidant additives for pharmaceutical and food manufacturing. Long-term in vivo toxicological tests should also be conducted to determine a safe dosage of OP extract

Antidiabetic treatment, obesity, and cancer risk in Algerian patients with type 2 diabetes mellitus

OBJECTIVE: Several studies have shown that antidiabetic drugs and obesity can modulate the risk of developing cancer. The objective of this study was to assess the impact of the use of antidiabetic drugs and obesity on the risk of developing cancers in type 2 diabetics. MATERIALS AND METHODS: Data for 1220 patients were collected from the processing of files and a pre-established questionnaire. The anthropobiological parameters and the associated treatment type have been unspecified. RESULTS: Women (OR=17.26; 95% CI=2.88-103.45, p<0.01), overweight individuals (OR=4.81; 95% CI=1.63-14.14, p<0.01) and hypertensive diabetic subjects (OR=3.82; 95% CI=1.39-10.49, p< 0.01) are more exposed to cancers. It is interesting to note that diabetic subjects treated with insulin have a reduced risk of developing cancer (OR=0.22; 95% CI=0.07-0.67, p<0.01). Diabetic subjects treated with metformin have a four and a half times higher risk of developing cancer (OR=4.61; 95% CI=1.48-14.37, p<0.01). CONCLUSIONS: In type 2 diabetic subjects, cancer is significantly linked to overweight, to the presence of essential hypertension in individuals under hypotensive as well as in patients treated with metformin

Effect of Dietary n-3 Polyunsaturated Fatty Acids on Oxidant/Antioxidant Status in Macrosomic Offspring of Diabetic Rats

The aim of this work was to determine the effect of dietary n-3 PUFA on oxidant/antioxidant status, in vitro very low and low density lipoprotein (VLDL-LDL), and VLDL-LDL-fatty acid composition in macrosomic pups of diabetic mothers. We hypothesized that n-3 PUFA would improve oxidative stress in macrosomia. Diabetes was induced in female Wistar rats fed with the ISIO diet (control) or with the EPAX diet (enriched in n-3 PUFAs), by streptozotocin. The macrosomic pups were killed at birth (day 0) and at adulthood (day 90). Lipid parameters and VLDL-LDL-fatty acid composition were investigated. The oxidant/antioxidant status was determined by measuring plasma oxygen radical absorbance capacity (ORAC), hydroperoxides, carbonyl proteins, and VLDL-LDL oxidation. Macrosomic rats of ISIO fed diabetic mothers showed an increase in plasma and VLDL-LDL-triglycerides and VLDL-LDL-cholesterol levels and altered VLDL-LDL-fatty acid composition. Plasma ORAC was low with high hydroperoxide and carbonyl protein levels. The in vitro oxidizability of VLDL-LDL was enhanced in these macrosomic rats. The EPAX diet corrected lipid parameters and improved oxidant/antioxidant status but increased VLDL-LDL susceptibility to oxidation. Macrosomia is associated with lipid abnormalities and oxidative stress. n-3 PUFA exerts favorable effects on lipid metabolism and on the oxidant/antioxidant status of macrosomic rats. However, there are no evident effects on VLDL-LDL oxidation